Home

Press Releases

BIO Unveils Strategic Initiative to Speed Scientific Breakthroughs, Develop Cures and Grow the Bio-Economy
June 29 2011

“Unleashing the Promise of Biotechnology: Advancing American Innovation to Cure Disease...

BIO Commends House for Easing Regulatory Burdens as Part of the Wall Street Reform and Consumer Protection Act of 2009
December 11 2009

BIO commends the House of Representatives for including provisions intended to ease small...

BIO Lauds Provisions to Give Small Companies SARBOX Relief and R&D Tax Credit Provisions
February 28 2008
Sarbanes-Oxley Rules Should Provide Additional Relief to Smaller Public Companies
December 12 2007

An Objective Definition of Small Company in Sarbanes-Oxley Rules Would Lessen the Compliance...

Greenwood Says More Needs to be Done on SOX Reform
July 25 2007

Jim Greenwood released the following statement following a vote today by the U.S. Securities...

Greenwood to Congress: Proposed Sarbanes-Oxley Reforms
June 6 2007

The changes proposed by the Securities and Exchange Commission (SEC) and the Public Companies...

Biotech Research and Development Will Benefit from Sarbanes-Oxley Changes
April 18 2007

BIO reiterates support as Senate Small Business Committee considers changes.

BIO Supports Legislation to Reduce SOX Burdens on Small Biotech Companies
March 15 2007

The biotechnology industry, hard-hit by the complex and burdensome regulations imposed by...

BIO Issues Statement On Anticipated Changes to Sarbanes-Oxley Implementation
December 13 2006

BIO President and CEO Jim Greenwood today commented on reports that the Securities and Exchange...

BIO Submits Comments Urging SEC to Ease Sarbanes-Oxley Burdens
September 13 2006

Jim Greenwood issued the following remarks regarding comments submitted Tuesday by BIO and a...

BIO Lauds Additional SEC Steps for Sarbanes-Oxley Reform
July 11 2006

Jim Greenwood issued the following statement in response to the Securities and Exchange...

Letters, Testimony & Comments

The 10th Anniversary of the Sarbanes-Oxley Act, Jeffrey S. Hatfield, President and Chief Executive Officer, Vitae Pharmaceuticals
July 26 2012
Jeffrey S. Hatfield, President and Chief Executive Officer of Vitae Pharmaceuticals, testified on behalf of BIO about the 10th anniversary of the Sarbanes-Oxley Act.
Medicare: Coverage Gap Discount Program Model Manufacturer Agreement
June 21 2010
BIO supports the coverage gap discount program and believes that it will increase patient access to life-saving and life enhancing therapies BIO provides comments on how the agreement could be modified to ensure the success of the program.
Sarbanes-Oxley in Financial Services Compromise: Sarbanes-Oxley 404(b) Legislative Text in the Wall Street Reform and Consumer Protection Act of 2009
BIO advocated for a provision in financial services reform that would ease regulatory burdens for small public biotechnology companies.
Sarbanes Oxley 404(b) recommendations made by the 2009 Government-Business Forum on Small Business Capital Formation

Press Releases

BIO Unveils Strategic Initiative to Speed Scientific Breakthroughs, Develop Cures and Grow the Bio-Economy
June 29 2011
“Unleashing the Promise of Biotechnology: Advancing American Innovation to Cure Disease and Save Lives” Provides Roadmap for Transformative Policy Changes
BIO Commends House for Easing Regulatory Burdens as Part of the Wall Street Reform and Consumer Protection Act of 2009
December 11 2009
BIO commends the House of Representatives for including provisions intended to ease small business regulatory burdens as part of the Wall Street Reform and Consumer Protection Act of 2009 (H.R. 4173) which passed today.
BIO Lauds Provisions to Give Small Companies SARBOX Relief and R&D Tax Credit Provisions
February 28 2008
Sarbanes-Oxley Rules Should Provide Additional Relief to Smaller Public Companies
December 12 2007
An Objective Definition of Small Company in Sarbanes-Oxley Rules Would Lessen the Compliance Burden on Small Biotechnology Firms
Greenwood Says More Needs to be Done on SOX Reform
July 25 2007
Jim Greenwood released the following statement following a vote today by the U.S. Securities and Exchange Commission’s (SEC) to approve the Public Company Accounting Oversight Board's (PCAOB) proposed auditing reforms to the Sarbanes-Oxley Act (SOX).
More Press Releases →